Antioxidants such as the haemoxygenase (HO)‐1 pathway may not be efficient in COPD, as reduced expression of HO‐1 has been observed in macrophages and bronchoalveolar lavage (BAL) fluid of COPD patients with a history of smoking.46 This evidence concerns the gene HMOX1 and chronic obstructive pulmonary disease.